Abstract
The aim of this study was to determine whether preventing increases in plasma cortisol during antecedent hypoglycemia preserves autonomic nervous system counterregulatory responses during subsequent hypoglycemia. Experiments were carried out on 15 (8 male/7 female) healthy, overnight-fasted subjects and 8 (4 male/4 female) age- and weight-matched patients with primary adrenocortical failure. 5 d before a study, patients had their usual glucocorticoid therapy replaced with a continuous subcutaneous infusion of cortisol programmed to produce normal daily circadian levels. Both groups underwent identical 2-d experiments. On day 1, insulin was infused at a rate of 1.5 mU/kg per min, and 2-h clamped hypoglycemia (53+/-2 mg/dl) was obtained during the morning and afternoon. The next morning, subjects underwent an additional 2-h hypoglycemic (53+/-2 mg/ dl) hyperinsulinemic clamp. In controls, day 2 steady state epinephrine, norepinephrine, pancreatic polypeptide, glucagon, growth hormone, and muscle sympathetic nerve activity were significantly blunted (P < 0.01) compared with day 1 hypoglycemia. In marked contrast, when increases of plasma cortisol were prevented in the patient group, day 2 neuroendocrine, muscle sympathetic nerve activity, hypoglycemic symptoms, and metabolic counterregulatory responses were equivalent with day 1 results. We conclude that (a) prevention of increases of cortisol during antecedent hypoglycemia preserves many critical autonomic nervous system counterregulatory responses to subsequent hypoglycemia; (b) hypoglycemia-induced increases in plasma cortisol levels are a major mechanism responsible for causing subsequent hypoglycemic counterregulatory failure; and (c) our results suggest that other mechanisms, apart from cortisol, do not play a major role in causing hypoglycemia-associated autonomic failure.
Full Text
The Full Text of this article is available as a PDF (222.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abumrad N. N., Rabin D., Diamond M. P., Lacy W. W. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism. 1981 Sep;30(9):936–940. doi: 10.1016/0026-0495(81)90074-3. [DOI] [PubMed] [Google Scholar]
- Amiel S. A., Sherwin R. S., Simonson D. C., Tamborlane W. V. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes. 1988 Jul;37(7):901–907. doi: 10.2337/diab.37.7.901. [DOI] [PubMed] [Google Scholar]
- Anderson E. A., Hoffman R. P., Balon T. W., Sinkey C. A., Mark A. L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991 Jun;87(6):2246–2252. doi: 10.1172/JCI115260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aynsley-Green A., Moncrieff M. W., Ratter S., Benedict C. R., Storrs C. N. Isolated ACTH deficiency. Metabolic and endocrine studies in a 7-year-old boy. Arch Dis Child. 1978 Jun;53(6):499–502. doi: 10.1136/adc.53.6.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boyle P. J., Nagy R. J., O'Connor A. M., Kempers S. F., Yeo R. A., Qualls C. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9352–9356. doi: 10.1073/pnas.91.20.9352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Causon R. C., Carruthers M. E., Rodnight R. Assay of plasma catecholamines by liquid chromatography with electrochemical detection. Anal Biochem. 1981 Sep 1;116(1):223–226. doi: 10.1016/0003-2697(81)90347-x. [DOI] [PubMed] [Google Scholar]
- Cherrington A. D., Lacy W. W., Chiasson J. L. Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest. 1978 Sep;62(3):664–677. doi: 10.1172/JCI109174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Connolly C. C., Steiner K. E., Stevenson R. W., Neal D. W., Williams P. E., Alberti K. G., Cherrington A. D. Regulation of glucose metabolism by norepinephrine in conscious dogs. Am J Physiol. 1991 Dec;261(6 Pt 1):E764–E772. doi: 10.1152/ajpendo.1991.261.6.E764. [DOI] [PubMed] [Google Scholar]
- Connolly C. C., Steiner K. E., Stevenson R. W., Neal D. W., Williams P. E., Alberti K. G., Cherrington A. D. Regulation of lipolysis and ketogenesis by norepinephrine in conscious dogs. Am J Physiol. 1991 Oct;261(4 Pt 1):E466–E472. doi: 10.1152/ajpendo.1991.261.4.E466. [DOI] [PubMed] [Google Scholar]
- Cox D. J., Gonder-Frederick L., Antoun B., Cryer P. E., Clarke W. L. Perceived symptoms in the recognition of hypoglycemia. Diabetes Care. 1993 Feb;16(2):519–527. doi: 10.2337/diacare.16.2.519. [DOI] [PubMed] [Google Scholar]
- Cryer P. E. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes. 1992 Mar;41(3):255–260. doi: 10.2337/diab.41.3.255. [DOI] [PubMed] [Google Scholar]
- Dagogo-Jack S. E., Craft S., Cryer P. E. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest. 1993 Mar;91(3):819–828. doi: 10.1172/JCI116302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis M. R., Mellman M., Shamoon H. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes. 1992 Oct;41(10):1335–1340. doi: 10.2337/diab.41.10.1335. [DOI] [PubMed] [Google Scholar]
- Davis M. R., Shamoon H. Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab. 1991 Nov;73(5):995–1001. doi: 10.1210/jcem-73-5-995. [DOI] [PubMed] [Google Scholar]
- Davis M. R., Shamoon H. Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma. J Clin Endocrinol Metab. 1991 Apr;72(4):788–792. doi: 10.1210/jcem-72-4-788. [DOI] [PubMed] [Google Scholar]
- Davis S. N., Dobbins R., Tarumi C., Jacobs J., Neal D., Cherrington A. D. Paradoxical insulin-induced increase in gluconeogenesis in response to prolonged hypoglycemia in conscious dogs. Am J Physiol. 1995 Mar;268(3 Pt 1):E521–E530. doi: 10.1152/ajpendo.1995.268.3.E521. [DOI] [PubMed] [Google Scholar]
- Davis S. N., Shavers C., Costa F., Mosqueda-Garcia R. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest. 1996 Aug 1;98(3):680–691. doi: 10.1172/JCI118839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
- Fagius J., Berne C. Changes of sympathetic nerve activity induced by 2-deoxy-D-glucose infusion in humans. Am J Physiol. 1989 Jun;256(6 Pt 1):E714–E720. doi: 10.1152/ajpendo.1989.256.6.E714. [DOI] [PubMed] [Google Scholar]
- Fagius J., Niklasson F., Berne C. Sympathetic outflow in human muscle nerves increases during hypoglycemia. Diabetes. 1986 Oct;35(10):1124–1129. doi: 10.2337/diab.35.10.1124. [DOI] [PubMed] [Google Scholar]
- HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
- Heller S. R., Cryer P. E. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes. 1991 Feb;40(2):223–226. doi: 10.2337/diab.40.2.223. [DOI] [PubMed] [Google Scholar]
- Hung W., Migeon C. J. Hypoglycemia in a two-year-old boy with adrenocorticotropic hormone (ACTH) deficiency (probably isolated) and adrenal medullary unresponsiveness to insulin-induced hypoglycemia. J Clin Endocrinol Metab. 1968 Feb;28(2):146–152. doi: 10.1210/jcem-28-2-146. [DOI] [PubMed] [Google Scholar]
- Lloyd B., Burrin J., Smythe P., Alberti K. G. Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem. 1978 Oct;24(10):1724–1729. [PubMed] [Google Scholar]
- Maran A., Taylor J., Macdonald I. A., Amiel S. A. Evidence for reversibility of defective counterregulation in a patient with insulinoma. Diabet Med. 1992 Oct;9(8):765–768. doi: 10.1111/j.1464-5491.1992.tb01889.x. [DOI] [PubMed] [Google Scholar]
- Mitrakou A., Fanelli C., Veneman T., Perriello G., Calderone S., Platanisiotis D., Rambotti A., Raptis S., Brunetti P., Cryer P. Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med. 1993 Sep 16;329(12):834–839. doi: 10.1056/NEJM199309163291203. [DOI] [PubMed] [Google Scholar]
- Nicholson W. E., Davis D. R., Sherrell B. J., Orth D. N. Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem. 1984 Feb;30(2):259–265. [PubMed] [Google Scholar]
- Powell A. M., Sherwin R. S., Shulman G. I. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits. J Clin Invest. 1993 Dec;92(6):2667–2674. doi: 10.1172/JCI116883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prager R., Wallace P., Olefsky J. M. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes. 1987 May;36(5):607–611. doi: 10.2337/diab.36.5.607. [DOI] [PubMed] [Google Scholar]
- Rebrin K., Steil G. M., Getty L., Bergman R. N. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 1995 Sep;44(9):1038–1045. doi: 10.2337/diab.44.9.1038. [DOI] [PubMed] [Google Scholar]
- Rudman D., Moffitt S. D., Fernhoff P. M., Blackston R. D., Faraj B. A. Epinephrine deficiency in hypocorticotropic hypopituitary children. J Clin Endocrinol Metab. 1981 Oct;53(4):722–729. doi: 10.1210/jcem-53-4-722. [DOI] [PubMed] [Google Scholar]
- Schwandt P., Richter W. O. Effects of pituitary peptides on fat mobilisation. Int J Obes. 1982;6 (Suppl 1):49–54. [PubMed] [Google Scholar]
- Sherwin R. S., Kramer K. J., Tobin J. D., Insel P. A., Liljenquist J. E., Berman M., Andres R. A model of the kinetics of insulin in man. J Clin Invest. 1974 May;53(5):1481–1492. doi: 10.1172/JCI107697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simonson D. C., Tamborlane W. V., DeFronzo R. A., Sherwin R. S. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann Intern Med. 1985 Aug;103(2):184–190. doi: 10.7326/0003-4819-103-2-184. [DOI] [PubMed] [Google Scholar]
- Veneman T., Mitrakou A., Mokan M., Cryer P., Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes. 1993 Sep;42(9):1233–1237. doi: 10.2337/diab.42.9.1233. [DOI] [PubMed] [Google Scholar]
- WALL J. S., STEELE R., DE BODO R. C., ALTSZULER N. Effect of insulin on utilization and production of circulating glucose. Am J Physiol. 1957 Apr;189(1):43–50. doi: 10.1152/ajplegacy.1957.189.1.43. [DOI] [PubMed] [Google Scholar]
- Wallin B. G., Sundlöf G., Eriksson B. M., Dominiak P., Grobecker H., Lindblad L. E. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand. 1981 Jan;111(1):69–73. doi: 10.1111/j.1748-1716.1981.tb06706.x. [DOI] [PubMed] [Google Scholar]
- Widom B., Simonson D. C. Intermittent hypoglycemia impairs glucose counterregulation. Diabetes. 1992 Dec;41(12):1597–1602. doi: 10.2337/diab.41.12.1597. [DOI] [PubMed] [Google Scholar]
- Wurtman R. J., Axelrod J. Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J Biol Chem. 1966 May 25;241(10):2301–2305. [PubMed] [Google Scholar]